Excellent response with alpelisib and bicalutamide for advanced salivary duct carcinoma with PIK3CA mutation and high androgen receptor expression-A case report

Document Type

Article

Publication Title

JCO Precision Oncology

First Page

744

Last Page

750

DOI

10.1200/PO.20.00436

Publication Date

1-1-2021

This document is currently not available here.

Share

COinS